Suppr超能文献

姜黄素包封的 SPC 和 HSPC 脂质体纳米颗粒对人膀胱癌细胞的选择性细胞摄取和细胞毒性。

Selective Cellular Uptake and Cytotoxicity of Curcumin-encapsulated SPC and HSPC Liposome Nanoparticles on Human Bladder Cancer Cells.

机构信息

Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.

Noncommunicable Diseases Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran.

出版信息

Curr Pharm Des. 2023;29(13):1046-1058. doi: 10.2174/1381612829666230331084848.

Abstract

BACKGROUND

Curcumin is a main bioactive constituent of turmeric (Curcuma longa L.) with pleiotropic health beneficial effects. However, poor bioavailability is the major barrier to the efficient pharmacological effects of curcumin in humans.

AIMS

The present study aimed to develop liposome formulations based on soybean phosphatidylcholine (SPC) and hydrogenated SPC (HSPC) to enhance the bioavailability of curcumin in bladder cancer cells.

METHODS

Curcumin was encapsulated in HSPC and SPC liposome nanoparticles using the solvent evaporation method. Physical properties, encapsulation efficiency (%), stability, and in vitro drug release of the prepared liposome formulations have been evaluated. The cellular uptake and cytotoxicity of curcumin-encapsulated nanoliposomes on bladder carcinoma HTB9 cell line and normal fibroblast L929 cell line were studied. DNA fragmentation, apoptosis, and genotoxicity assessments have been carried out to determine the molecular mechanisms underlying the cytotoxic effects of liposomal curcumin formulations on bladder cancer cells.

RESULTS

The results indicated that curcumin could be efficiently encapsulated in the HSPC and SPC liposome formulations. The liposomal curcumin formulations have shown shelf-life stability for 14 weeks at 4°C. The accelerated stability testing showed that curcumin encapsulated in nanoliposomes was significantly (p < 0.001) more stable than free curcumin at various pH degrees ranging from alkaline to acidic pH. The in vitro drug release study showed curcumin to be sustainably released from the liposome nanoparticles. Of note, SPC and HSPC nanoliposome formulations significantly increased the cellular uptake and cytotoxicity of curcumin on bladder cancer HTB9 cells. Mechanistically, liposomal curcumin was found to exert a selective inhibitory effect on the viability of cancer cells by inducing apoptosis and DNA damage.

CONCLUSION

In conclusion, SPC and HSPC liposome nanoparticles can significantly increase the stability and bioavailability of curcumin, which are important for improving its pharmacological effect.

摘要

背景

姜黄素是姜黄(Curcuma longa L.)的主要生物活性成分,具有多种有益健康的作用。然而,生物利用度差是姜黄素在人体中发挥有效药理作用的主要障碍。

目的

本研究旨在开发基于大豆卵磷脂(SPC)和氢化 SPC(HSPC)的脂质体制剂,以提高姜黄素在膀胱癌细胞中的生物利用度。

方法

采用溶剂蒸发法将姜黄素包封于 HSPC 和 SPC 脂质体纳米粒中。评价了所制备的脂质体制剂的物理性质、包封效率(%)、稳定性和体外药物释放。研究了载姜黄素纳米脂质体对膀胱癌 HTB9 细胞系和正常成纤维细胞 L929 细胞系的细胞摄取和细胞毒性。进行 DNA 片段化、细胞凋亡和遗传毒性评估,以确定脂质体姜黄素制剂对膀胱癌细胞细胞毒性作用的分子机制。

结果

结果表明,姜黄素可以有效地包封在 HSPC 和 SPC 脂质体制剂中。脂质体姜黄素制剂在 4°C 下稳定 14 周。加速稳定性试验表明,与游离姜黄素相比,包封在纳米脂质体中的姜黄素在从碱性到酸性 pH 值的各种 pH 度下都显著(p < 0.001)更稳定。体外药物释放研究表明,姜黄素可以从脂质体纳米粒中持续释放。值得注意的是,SPC 和 HSPC 纳米脂质体制剂显著增加了姜黄素对膀胱癌 HTB9 细胞的细胞摄取和细胞毒性。机制上,发现脂质体姜黄素通过诱导细胞凋亡和 DNA 损伤对癌细胞的活力产生选择性抑制作用。

结论

总之,SPC 和 HSPC 脂质体纳米粒可以显著提高姜黄素的稳定性和生物利用度,这对于提高其药理作用非常重要。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验